ReShape Lifesciences (RSLS) Short Interest Ratio & Short Volume → Dems have chosen Biden replacement? (From Paradigm Press) (Ad) Free RSLS Stock Alerts $0.18 +0.01 (+6.02%) (As of 05/17/2024 ET) Add Compare Share Share Short InterestStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media ReShape Lifesciences Short Interest DataCurrent Short Volume350,100 sharesPrevious Short Volume487,800 sharesChange Vs. Previous Month-28.23%Dollar Volume Sold Short$58,116.60Short Interest Ratio / Days to Cover0.8Last Record DateApril 30, 2024Outstanding Shares13,140,000 sharesFloat Size20,810,000 sharesShort Percent of Float1.68%Today's Trading Volume6,340,195 sharesAverage Trading Volume194,585 sharesToday's Volume Vs. Average3,258% Short Selling ReShape Lifesciences ? Sign up to receive the latest short interest report for ReShape Lifesciences and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatRSLS Short Interest Over TimeRSLS Days to Cover Over TimeRSLS Percentage of Float Shorted Over Time Ad Paradigm PressDems have chosen Biden replacement?On November 16, 2023… Joe Biden accidentally revealed the name of the candidate… Who will replace him in the 2024 presidential election.See who it is HERE. ReShape Lifesciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/2024350,100 shares $58,116.60 -28.2%1.7%0.8 $0.17 4/15/2024487,800 shares $80,238.22 -33.1%2.3%0.9 $0.16 3/31/2024729,300 shares $134,482.92 +70.1%3.5%0.9 $0.18 3/15/2024428,700 shares $69,663.75 -43.3%2.1%0.4 $0.16 2/29/2024756,200 shares $127,268.46 -9.0%4.0%0.1 $0.17 2/15/2024830,800 shares $143,063.76 -3.7%4.4%0.2 $0.17 Get the Latest News and Ratings for RSLS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for ReShape Lifesciences and its competitors with MarketBeat's FREE daily newsletter. 1/31/2024862,400 shares $180,327.84 -41.3%4.6%0.2 $0.21 1/15/20241,470,000 shares $378,672.00 +102.2%14.0%0.2 $0.26 12/31/2023726,900 shares $181,506.93 -93.6%5.6%0.1 $0.25 12/15/202311,270,000 shares $3.73 million +5,386.9%86.9%1.5 $0.33 11/30/2023205,400 shares $46,851.74 -66.6%1.6%0.1 $0.23 11/15/2023614,800 shares $150,195.64 -63.2%4.7%0.2 $0.24 10/31/20231,670,000 shares $413,659.00 +77.7%14.0%0.5 $0.25 10/15/2023939,900 shares $284,601.72 +178.7%7.9%0.5 $0.30 9/30/2023337,300 shares $114,007.40 +112.8%2.8%1.5 $0.34 9/15/2023158,500 shares $118,082.50 +335.4%4.8%1.1 $0.75 8/31/202336,400 shares $33,855.64 +658.3%1.1%0.2 $0.93 8/15/20234,800 shares $5,712.00 -79.1%0.2%0 $1.19 7/31/202323,000 shares $32,660.00 +12.2%0.8%0.1 $1.42 7/15/202320,500 shares $30,750.00 -74.8%0.7%0.1 $1.50 6/30/202381,300 shares $120,324.00 +95.0%2.9%0.3 $1.48 6/15/202341,700 shares $91,740.00 -59.6%1.5%0.1 $2.20 5/31/2023103,100 shares $249,502.00 -7.9%3.7%0.4 $2.42 5/15/2023111,900 shares $275,274.00 -11.8%4.0%0.4 $2.46 6/15/2021100 shares $213.33 No ChangeN/A0.1 $2.13 5/28/2021100 shares $620.00 No ChangeN/A0.1 $6.20 4/15/2021100 shares $440.00 No ChangeN/A0.2 $4.40 3/31/2021100 shares $420.00 No ChangeN/A0.1 $4.20 2/12/20211,000 shares $9,000.00 +150.0%N/A0.3 $9.00 1/29/2021400 shares $2,486.40 +300.0%N/A0 $6.22 1/15/2021100 shares $400.00 No ChangeN/A0.1 $4.00 12/31/2020100 shares $375.00 No ChangeN/A0.2 $3.75 12/15/2020100 shares $445.00 No ChangeN/A0.1 $4.45 11/30/2020100 shares $445.00 No ChangeN/A0.5 $4.45 11/15/2020100 shares $410.00 No ChangeN/A0.1 $4.10 10/30/2020100 shares $345.00 No ChangeN/A0.1 $3.45 10/15/2020100 shares $350.00 No ChangeN/A0.3 $3.50 9/30/2020100 shares $400.00 No ChangeN/A0 $4.00 9/15/2020100 shares $325.00 No ChangeN/A0.1 $3.25 8/31/2020100 shares $468.00 No ChangeN/A0 $4.68Dems have chosen Biden replacement? (Ad)On November 16, 2023… Joe Biden accidentally revealed the name of the candidate… Who will replace him in the 2024 presidential election.See who it is HERE. RSLS Short Interest - Frequently Asked Questions What is ReShape Lifesciences' current short interest? Short interest is the volume of ReShape Lifesciences shares that have been sold short but have not yet been covered or closed out. As of April 30th, traders have sold 350,100 shares of RSLS short. 1.68% of ReShape Lifesciences' shares are currently sold short. Learn More on ReShape Lifesciences' current short interest. What is a good short interest ratio for ReShape Lifesciences? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. RSLS shares currently have a short interest ratio of 1.0. Learn More on ReShape Lifesciences's short interest ratio. What is a good short interest percentage for ReShape Lifesciences? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.68% of ReShape Lifesciences' floating shares are currently sold short. Is ReShape Lifesciences' short interest increasing or decreasing? ReShape Lifesciences saw a decrease in short interest during the month of April. As of April 30th, there was short interest totaling 350,100 shares, a decrease of 28.2% from the previous total of 487,800 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is ReShape Lifesciences' float size? ReShape Lifesciences currently has issued a total of 13,140,000 shares. Some of ReShape Lifesciences' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. ReShape Lifesciences currently has a public float of 20,810,000 shares. How does ReShape Lifesciences' short interest compare to its competitors? 1.68% of ReShape Lifesciences' shares are currently sold short. Here is how the short interest of companies compare to ReShape Lifesciences: Dynatronics Co. (2.09%), Quoin Pharmaceuticals, Ltd. (0.26%), Sintx Technologies, Inc. (42.11%), INVO Bioscience, Inc. (1.21%), Assure Holdings Corp. (0.84%), Bluejay Diagnostics, Inc. (3.91%), Tenon Medical, Inc. (0.66%), Sharps Technology, Inc. (1.27%), Nemaura Medical Inc. (0.34%), Acutus Medical, Inc. (1.44%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short ReShape Lifesciences stock? Short selling RSLS is an investing strategy that aims to generate trading profit from ReShape Lifesciences as its price is falling. RSLS shares are trading up $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against ReShape Lifesciences? A short squeeze for ReShape Lifesciences occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of RSLS, which in turn drives the price of the stock up even further. How often is ReShape Lifesciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including RSLS, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: DYNT Short Interest Data QNRX Short Interest Data SINT Short Interest Data INVO Short Interest Data IONM Short Interest Data BJDX Short Interest Data TNON Short Interest Data STSS Short Interest Data NMRD Short Interest Data AFIB Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:RSLS) was last updated on 5/18/2024 by MarketBeat.com Staff From Our PartnersObama’s Forever Term [exposed]Porter & CompanyThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingMost important medical advance in 100 yearsThe Oxford ClubThe Presidential candidate you should REALLY be worried aboutStansberry ResearchForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm Press[URGENT] DO NOT Touch These AI Stocks!Weiss RatingsClaim Your Complimentary Bitcoin RewardCrypto Swap Profits